Company profile: BIA Separations
1.1 - Company Overview
Company description
- Provider of proprietary monolithic chromatography columns based on CIM Convective Interaction Media technology for production, purification, and analysis of large biomolecules, including viruses, plasmid DNA, exosomes, antibodies, bacteriophages, and large proteins. Offers CIMmultus preparative and CIMac analytical columns, PATfix analytical standards, and Cornerstone services and process development support.
Products and services
- CIMac Analytical Columns: Analytical-scale CIM columns architected for fast, reproducible HPLC monitoring and quantitation of proteins, viruses, plasmid DNA, and other large biomolecules
- CIMmultus Preparative Columns: Pre-packed CIM monoliths with large flow-through channels constructed for processing large proteins, viruses, VLPs, and pDNA, supplied in single-use or multi-use formats for preparative workflows
- Monolithic Chromatography Columns: Industrial-grade CIM Convective Interaction Media columns engineered for production, purification, and analysis of viruses, plasmid DNA, exosomes, antibodies, bacteriophages, and large proteins via short monolithic matrices
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BIA Separations
Cytoo
HQ: France
Website
- Description: Provider of life science research products and cell-based assay solutions that make cellular analysis robust and reliable by decreasing cell variability, including high content screening (96-well, 384 format coming), micropatterning technology, OncoSpheres 3D spheroids, Arena and custom chips, and standard, starter, and motility plates for high-throughput, multiplexed analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytoo company profile →
Caprotec Bioanalytics
HQ: United States
Website
- Description: Provider of proprietary capture protein technology for pharmaceutical, agrochemical, and biotech industries, including Capture Compound Mass Spectrometry (CCMS) based on multifunctional small molecules (Capture Compounds) used to target, capture, and isolate, reducing the complexity of protein mixtures and samples in a targeted and directed manner.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caprotec Bioanalytics company profile →
Axion Biosystems
HQ: United States
Website
- Description: Provider of multi-electrode array and impedance-based platforms for real-time, continuous, label-free cellular analysis, including monitoring of proliferation, viability, morphology, attachment, signaling, and immune cell-mediated killing. Offers single- and multi-well systems, high-throughput formats, automation modules, and integrated circuits to eliminate stimulation artifacts for research, clinical, and drug discovery markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axion Biosystems company profile →
Stilla Technologies
HQ: France
Website
- Description: Provider of digital PCR solutions to accelerate next-generation genetic testing, including the Nio System, an all-in-one 7-color, continuous-loading instrument for high-throughput analysis; the naica System, a multiplex dPCR platform with up to six fluorescent channels; ready-to-use digital PCR kits and assays; chips and reagents; and analysis software for image analysis and data export.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stilla Technologies company profile →
PhoreMost
HQ: United Kingdom
Website
- Description: Provider of phenotypic screening and targeted protein degradation solutions, including the SITESEEKER® platform using PROTEINi® libraries to identify novel drug targets and druggable sites in live cells, and GlueSEEKER™ to discover molecular glue degraders. Offers an oncology-focused pipeline of first-in-class targets and E3 ligase-based degraders, and partnering services applying SITESEEKER® across therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PhoreMost company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BIA Separations
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BIA Separations
2.2 - Growth funds investing in similar companies to BIA Separations
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BIA Separations
4.2 - Public trading comparable groups for BIA Separations
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →